United Kingdom Wildlife Health Market Size, Share, and COVID-19 Impact Analysis, By Species (Mammals, Birds, Fish, Reptiles, Amphibians), By Offering (Pharmaceuticals, Medical Devices, Veterinary Services), By End User (Zoos, Wildlife Sanctuaries, Wildlife Rescue & Rehab Centers, and Others), and United Kingdom Wildlife Health Market Insights, Industry Trend, Forecasts to 2035.

United Kingdom Wildlife Health Market Insights Forecasts to 2035

• The United Kingdom Wildlife Health Market Size was estimated at USD 130.43 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 9.75% from 2025 to 2035
• The United Kingdom Wildlife Health Market Size is Expected to Reach USD 363.11 Million by 2035

According to a research report published by Spherical Insights & Consulting, The United Kingdom Wildlife Health Market Size is Anticipated to reach USD 363.11 million By 2035, Growing at a CAGR of 9.75% from 2025 to 2035. Significant research and development (R&D) operations carried out by leading companies, the rising incidence of zoonotic illnesses, and the expanding government expenditure to improve animal healthcare are some of the main drivers driving the market.

Market Overview

The United Kingdom wildlife health market refers to the marketplace, which is a subsegment of the healthcare sector that focuses on the production and application of medical services for wildlife to enhance their health and monitoring periodically. This market encompasses pharmaceutical products and key industry players, along with veterinary experts and caretaker staff. It includes giving proper veterinary care, preventing illnesses, and preserving and advancing optimum health. It is necessary for a number of reasons, including public health, wildlife protection, sustainable agriculture, and ethical considerations. Regular veterinary examinations, immunization programs, healthy diet, hygiene, illness monitoring, and efficient parasite and infection control are just a few of the many procedures that include it. Veterinarians and other animal healthcare specialists are crucial in identifying and treating diseases, implementing preventative measures, and instructing pet owners and caregivers. Furthermore, government support, the UK government announced £10 million in new funding to enhance biosecurity measures and combat animal and plant diseases. This initiative, led by the Animal and Plant Health Agency (APHA), will use advanced genome sequencing technologies to detect, identify, and track pathogens with precision. This funding is expected to strengthen UK agriculture, livestock, and environmental protection, as invasive species alone cost the UK economy an estimated £4 billion annually.

Report Coverage

This research report categorizes the market for the United Kingdom wildlife health market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom wildlife health market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom wildlife health market.

Driving Factors

The market for United Kingdom wildlife health is driven by the increasing technology innovations and developments in healthcare, such as monitoring systems that allow for real-time health monitoring by tracking vital signs like temperature, activity levels, feeding rates, etc. The market grew as a result of the rise and spread of zoonotic illnesses as well as increased public awareness of animal health. Furthermore, government programs and technical developments in healthcare diagnostics for veterinary are propelling the market's expansion. Moreover, the increasing potential of infectious diseases brought on by urbanization, deforestation, and climate change, and mostly by increased human-wildlife interactions, boosts this market expansion and new growing opportunities.

Restraining Factors

The market expansion is constrained by some variables, such as government restrictions on the approval of animal medications, and the high cost may prevent some firms, specifically small enterprises, from using it. Furthermore, the market's expansion is being hampered by a lack of understanding regarding vertebrate health and fake medications, which cause an adverse impact on the wildlife ecosystem. Most of all them the main reason is to catch up vertebrates if they are living large area of a sector, which also delays for periodic inception process.

Market Segmentation

The United Kingdom wildlife health market share is classified into species, offering, and end user.

• The mammals segment held the highest share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period.

The United Kingdom wildlife health market is segmented by species into mammals, birds, fish, reptiles, and amphibians. Among these, the mammals segment held the highest share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period. This segment growth contributed to the market expansion because of their diverse habitats and intricate physiology, they are important subjects for study and observation. As a result, the necessity to control and stop disease outbreaks, preserve biodiversity, and maintain public health is driving the increased attention on mammals, which in turn is contributing to the market's importance.

• The pharmaceuticals segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period.

The United Kingdom wildlife health market is segmented by offering into pharmaceuticals, medical devices, and veterinary services. Among these, the pharmaceuticals segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period. This is because of their vital function in managing and treating diseases in a variety of wildlife species. The increasing need for efficient treatment choices and preventative measures to address both new and pre-existing health issues is another factor contributing to its rise.

• The wildlife rescue & rehab centers segment accounted for a significant share in 2024 and is anticipated to grow at a rapid pace over the forecast period.

The United Kingdom wildlife health market is segmented by end user into zoos, wildlife sanctuaries, wildlife rescue & rehab centers, and others. Among these, the wildlife rescue & rehab centers segment accounted for a significant share in 2024 and is anticipated to grow at a rapid pace over the forecast period. This is due to rescuing them, as safeguarding stranded, injured, or wounded animals is becoming more important. Also, the value of wildlife conservation and stopping the extinction of wild animals will rise in consumer minds.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom wildlife health market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Wildlife Trust Consultancies
• Wildforce Ltd
• WWF-UK
• Animalcare Group plc
• Felcana
• Smartbell
• Pruex Ltd
• Others

Recent Developments:

• In May 2025, the National Office of Animal Health (NOAH) urged UK and EU policymakers to establish a veterinary medicines agreement to ensure continued cooperation on animal health and welfare. Since Brexit, the lack of formal regulatory alignment has created challenges in medicine availability, innovation, and cost efficiency. NOAH, alongside AnimalhealthEurope, advocated for a dedicated veterinary medicines arrangement—either as a standalone deal or as part of a broader Sanitary and Phytosanitary (SPS) Agreement.

• In January 2025, Ceva Animal Health and Touchlight entered into a long-term collaboration to develop and manufacture new dbDNA vaccines and therapeutics for animal health. This agreement granted Ceva the rights to use Touchlight’s dbDNA technology, which enabled rapid, high-purity enzymatic DNA production while eliminating antibiotic resistance genes. The partnership aimed to bring innovative DNA vaccine products to market, complementing Ceva’s existing nucleic acid vaccine.

• In July 2023, the India-UK partnership aimed to tackle farmed animal diseases and veterinary antimicrobial resistance (Vet-AMR) through collaborative research. This initiative had been funded by the Biotechnology and Biological Sciences Research Council (BBSRC) in the UK and the Department of Biotechnology (DBT) in India, with a total funding pool of £10 million. The goal had been to advance the mechanistic understanding of host-pathogen interactions in farmed animals and improve disease management.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom wildlife health market based on the below-mentioned segments

United Kingdom Wildlife Health Market, By Species

• Mammals
• Birds
• Fish
• Reptiles
• Amphibians

United Kingdom Wildlife Health Market, By Offering

• Pharmaceuticals
• Medical Devices
• Veterinary Services

United Kingdom Wildlife Health Market, By End User

• Zoos
• Wildlife Sanctuaries
• Wildlife Rescue & Rehab Centers
• Others